Table 2.
T = 24 h | T = 72 h | |||||
pg/mL | WT | Nlrp3−/− | Asc−/− | WT | Nlrp3−/− | Asc−/− |
Lung | ||||||
TNF-α | 806 ± 109 | 645 ± 74 | 482 ± 76 | 1,276 ± 131 | 1,004 ± 157 | 814 ± 80 |
IL-6 | 841 ± 119 | 783 ± 105 | 743 ± 171 | 8,066 ± 2,164 | 5,735 ± 717 | 12,295 ± ± 1,607 |
KC | 13,083 ± 2,098 | 5,950 ± 823** | 7,792 ± 1,870* | 41,223 ± 9,319 | 53,639 ± 4,165 | 55,093 ± 4,907 |
IL-1β | 1,660 ± 326 | 659 ± 56** | 617 ± 12** | 29,571 ± 3,549 | 2,083 ± 667*** | 760 ± 104*** |
BALF | ||||||
TNF-α | 1,102 ± 332 | 4,200 ± 774*** | 1,492 ± 273 | 6,518 ± 2,446 | 13,430 ± 2,456 | 13,908 ± 1,899 |
IL-6 | 340 ± 20 | 439 ± 49 | 458 ± 52 | 14,777 ± 4,636 | 6,265 ± 899 | 23,992 ± 6,707 |
KC | 5,105 ± 677 | 1,999 ± 283** | 2,958 ± 336* | 36,591 ± 8,648 | 60,000 ± 598* | 60,000 ± 598* |
IL-1β | 350 ± 45 | 280 ± 22 | 245 ± 13* | 2,494 ± 413 | 1,727 ± 368 | 1,677 ± 115 |
MPO (ng/mL) | 1,327 ± 397 | 3,293 ± 612 | 3,990 ± 1,000 | 6,757 ± 271 | 5,699 ± 524 | 5,217 ± 334** |
Plasma | ||||||
TNF-α | 8 ± 1 | 13 ± 1** | 6 ± 1* | 1,402 ± 1,230 | 2,874 ± 1,556* | 5,343 ± 1,763* |
IL-6 | 196 ± 28 | 226 ± 28 | 91 ± 8*** | 5,773 ± 1,660 | 10,000 ± 267 | 9,734 ± 377 |
MCP-1 | 189 ± 21 | 145 ± 10 | 83 ± 13** | 1,728 ± 677 | 4,550 ± 354** | 2,600 ± 394 |
IFN-γ | 23 ± 2 | 9 ± 1** | 4 ± 1** | 321 ± 173 | 3,051 ± 459*** | 2,301 ± 619** |
IL-12p70 | 12 ± 2 | 16 ± 2 | 9 ± 2 | 7 ± 1 | 200 ± 25** | 94 ± 25** |
IL-10 | ND | ND | ND | 11 ± 3 | 7 ± 1 | 31 ± 10* |
IL-1β | − | − | − | 1133 ± 430 | 252 ± 48 | 150 ± 1* |
Cytokine levels in lung homogenate, broncho-alveolar fluid (BALF), and plasma measured after intranasal infection with 5 × 102 CFU B pseudomallei. Wild-type (WT) and Nlrp3−/− and Asc−/− mice were sacrificed 24 or 72 h after infection. Data are represented as means ± SEM (n = 6–8/group).
IFN-γ indicates interferon-γ; IL, interleukin; KC, keratinocyte chemoattractant; MCP-1, monocyte chemoattractant protein-1; MPO, myeloperoxidase; ND, not detectable; TNF-α, tumor necrosis factor-α.
*P <0.05.
**P <0.01.
***P <0.001 compared with WT mice.